Ashish Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ashish Kumar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Perumal Vivekanandan
Kusuma School of Biological Sciences, Indian Institute of Technology Delhi
2 shared publications Ankan Chakraborty
Kusuma School of Biological Sciences, Indian Institute of Technology, Delhi, New Delhi 110016, India
1 shared publication- Bishwajit Kundu
Kusuma School of Biological Sciences Indian Institute of Technology Delhi New Delhi India
1 shared publication G. K. Koutu
Department of Plant Breeding and Genetics, College of Agriculture, Jawaharlal Nehru Krishi Vishwa Vidyalaya, Jabalpur, India
1 shared publicationKritika Singh
Kusuma School of Biological Sciences, Indian Institute of Technology, Delhi, New Delhi 110016, India
1 shared publicationLokesh Gaur
Department of Plant Breeding and Genetics, College of Agriculture, Jawaharlal Nehru Krishi Vishwa Vidyalaya, Jabalpur, India
1 shared publication
Latest Publications
- 30 May 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (6) , 1990-2001
The Salmonella typhi Cell Division Activator Protein StCAP Impacts Pathogenesis by Influencing Critical Molecular Events
Conserved molecular signatures in multidrug-resistant Salmonella typhi can serve as novel therapeutic targets for mitigation of infection. In this regard, we present the S. typhi cell division activator protein (StCAP) as a conserved target across S. typhi variants. From in silico and fluorimetric assessments, we found that StCAP is a DNA-binding protein. Replacement of the identified DNA-interacting residue Arg(34) of StCAP with Ala(34) showed a dramatic (15-fold) increase in K-d value compared to the wild type (K-d 546 nm) as well as a decrease in thermal stability (10 degrees C shift). Out of the two screened molecules against the DNA-binding pocket of StCAP, eltrombopag, and nilotinib, the former displayed better binding. Eltrombopag inhibited the stand-alone S. typhi culture with an IC50 of 38 mu M. The effect was much more pronounced on THP-1-derived macrophages (T1Mac) infected with S. typhi where colony formation was severely hindered with IC50 reduced further to 10 mu M. Apoptotic protease activating factor1 (Apaf1), a key molecule for intrinsic apoptosis, was identified as an StCAP-interacting partner by pull-down assay against T1Mac. Further, StCAP-transfected T1Mac showed a significant increase in LC3 II (autophagy marker) expression and downregulation of caspase 3 protein. From these experiments, we conclude that StCAP provides a crucial survival advantage to S. typhi during infection, thereby making it a potent alternative therapeutic target.
- 30 May 2024
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (6) , 1990-2001
The Salmonella typhi Cell Division Activator Protein StCAP Impacts Pathogenesis by Influencing Critical Molecular Events
Conserved molecular signatures in multidrug-resistant Salmonella typhi can serve as novel therapeutic targets for mitigation of infection. In this regard, we present the S. typhi cell division activator protein (StCAP) as a conserved target across S. typhi variants. From in silico and fluorimetric assessments, we found that StCAP is a DNA-binding protein. Replacement of the identified DNA-interacting residue Arg(34) of StCAP with Ala(34) showed a dramatic (15-fold) increase in K-d value compared to the wild type (K-d 546 nm) as well as a decrease in thermal stability (10 degrees C shift). Out of the two screened molecules against the DNA-binding pocket of StCAP, eltrombopag, and nilotinib, the former displayed better binding. Eltrombopag inhibited the stand-alone S. typhi culture with an IC50 of 38 mu M. The effect was much more pronounced on THP-1-derived macrophages (T1Mac) infected with S. typhi where colony formation was severely hindered with IC50 reduced further to 10 mu M. Apoptotic protease activating factor1 (Apaf1), a key molecule for intrinsic apoptosis, was identified as an StCAP-interacting partner by pull-down assay against T1Mac. Further, StCAP-transfected T1Mac showed a significant increase in LC3 II (autophagy marker) expression and downregulation of caspase 3 protein. From these experiments, we conclude that StCAP provides a crucial survival advantage to S. typhi during infection, thereby making it a potent alternative therapeutic target.
- Open Access
- 14 December 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (1) , 105567
RNA G-quadruplexes inhibit translation of the PE/PPE transcripts in Mycobacterium tuberculosis
- 14 December 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (1) , 105567
Open AccessRNA G-quadruplexes inhibit translation of the PE/PPE transcripts in Mycobacterium tuberculosis
- 27 July 2022
- Published by Springer Nature in Journal of Plant Biochemistry and Biotechnology
- Vol. 32 (2) , 225-238
Genetic diversity of farmers’ varieties of rice of central India using microsatellite and blast linked markers
- 27 July 2022
- Published by Springer Nature in Journal of Plant Biochemistry and Biotechnology
- Vol. 32 (2) , 225-238
Genetic diversity of farmers’ varieties of rice of central India using microsatellite and blast linked markers
Biogenesis, characterization, and functions of mirtrons
MicroRNAs (miRNAs) are major post‐transcriptional regulators of gene expression. They base pair with the complementary target mRNA at the 3′UTR and modulate cellular processes by repressing the mRNA translation or degrading the mRNA. There are well‐documented mechanisms of biogenesis of miRNA; however, a sizeable number of miRNAs are also produced by non‐canonical pathways. Mirtrons represent a predominant class of non‐canonical miRNAs. Mirtrons originate from intronic regions and are produced in a splicing‐dependent and Drosha‐independent manner. Mirtrons constitute about 15% of all miRNAs produced in a human body and have caught attention of researchers worldwide due to their unconventional origin, sequence characteristics, evolutionary dynamics, ability to regulate variety of cellular processes and their immense potential in disease therapeutics. In this comprehensive review we collate the research done in the past decade including biogenesis, sequence characteristics, regulation, and emerging therapeutic roles of mirtrons.This article is categorized under: RNA Processing > Processing of Small RNAs Regulatory RNAs/RNAi/Riboswitches > Biogenesis of Effector Small RNAs Regulatory RNAs/RNAi/Riboswitches > RNAi: Mechanisms of Action
Biogenesis, characterization, and functions of mirtrons
MicroRNAs (miRNAs) are major post‐transcriptional regulators of gene expression. They base pair with the complementary target mRNA at the 3′UTR and modulate cellular processes by repressing the mRNA translation or degrading the mRNA. There are well‐documented mechanisms of biogenesis of miRNA; however, a sizeable number of miRNAs are also produced by non‐canonical pathways. Mirtrons represent a predominant class of non‐canonical miRNAs. Mirtrons originate from intronic regions and are produced in a splicing‐dependent and Drosha‐independent manner. Mirtrons constitute about 15% of all miRNAs produced in a human body and have caught attention of researchers worldwide due to their unconventional origin, sequence characteristics, evolutionary dynamics, ability to regulate variety of cellular processes and their immense potential in disease therapeutics. In this comprehensive review we collate the research done in the past decade including biogenesis, sequence characteristics, regulation, and emerging therapeutic roles of mirtrons.This article is categorized under: RNA Processing > Processing of Small RNAs Regulatory RNAs/RNAi/Riboswitches > Biogenesis of Effector Small RNAs Regulatory RNAs/RNAi/Riboswitches > RNAi: Mechanisms of Action